share_log

Altria | 8-K: ALTRIA REPORTS 2024 SECOND-QUARTER AND FIRST-HALF RESULTS; NARROWS 2024 FULL-YEAR EARNINGS GUIDANCE

Altria | 8-K: ALTRIA REPORTS 2024 SECOND-QUARTER AND FIRST-HALF RESULTS; NARROWS 2024 FULL-YEAR EARNINGS GUIDANCE

奧馳亞 | 8-K:奧馳亞公佈2024年第二季度和上半年業績;縮小2024年全年收益預期
美股SEC公告 ·  07/31 04:06

Moomoo AI 已提取核心訊息

Altria Group reported Q2 2024 net revenues of $6.21 billion, down 4.6% YoY, and adjusted diluted EPS of $1.31, unchanged from Q2 2023. The company narrowed its 2024 full-year adjusted diluted EPS guidance to $5.07-$5.15, representing 2.5-4.0% growth from 2023.Smokeable products segment revenues decreased 5.6% to $5.50 billion, while oral tobacco products segment revenues increased 4.6% to $711 million. Reported domestic cigarette shipment volume declined 13.0% YoY, primarily due to industry decline and retail share losses.Altria recorded a $2.7 billion pre-tax gain from selling IQOS commercialization rights and a $354 million non-cash impairment charge for the Skoal trademark. The company repurchased 53.9 million shares at an average price of $44.50 under its $2.4 billion accelerated share repurchase program.
Altria Group reported Q2 2024 net revenues of $6.21 billion, down 4.6% YoY, and adjusted diluted EPS of $1.31, unchanged from Q2 2023. The company narrowed its 2024 full-year adjusted diluted EPS guidance to $5.07-$5.15, representing 2.5-4.0% growth from 2023.Smokeable products segment revenues decreased 5.6% to $5.50 billion, while oral tobacco products segment revenues increased 4.6% to $711 million. Reported domestic cigarette shipment volume declined 13.0% YoY, primarily due to industry decline and retail share losses.Altria recorded a $2.7 billion pre-tax gain from selling IQOS commercialization rights and a $354 million non-cash impairment charge for the Skoal trademark. The company repurchased 53.9 million shares at an average price of $44.50 under its $2.4 billion accelerated share repurchase program.
奧馳亞集團公佈2024年第二季度淨收入爲62.1億,較去年同期下降4.6%,調整後的攤薄後每股收益爲$1.31,與2023年第二季度持平。公司將2024全年調整後的攤薄後每股收益指引下調至$5.07-$5.15,較2023年增長2.5%-4.0%。可吸菸產品部門收入下降5.6%至55億,而口腔煙草製品部門收入增加4.6%至71100萬。報告的國內香菸出貨成交量同比下降13.0%,主要由於行業衰退和零售市場份額損失。奧馳亞記錄了來自銷售IQOS商業化權利的27億稅前收益,以及對Skoal商標的35400萬無形資產減值費用。公司在其24億加速股票回購計劃下以平均價格$44.50回購了5390萬股股份。
奧馳亞集團公佈2024年第二季度淨收入爲62.1億,較去年同期下降4.6%,調整後的攤薄後每股收益爲$1.31,與2023年第二季度持平。公司將2024全年調整後的攤薄後每股收益指引下調至$5.07-$5.15,較2023年增長2.5%-4.0%。可吸菸產品部門收入下降5.6%至55億,而口腔煙草製品部門收入增加4.6%至71100萬。報告的國內香菸出貨成交量同比下降13.0%,主要由於行業衰退和零售市場份額損失。奧馳亞記錄了來自銷售IQOS商業化權利的27億稅前收益,以及對Skoal商標的35400萬無形資產減值費用。公司在其24億加速股票回購計劃下以平均價格$44.50回購了5390萬股股份。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息